InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: ziploc_1 post# 381634

Thursday, 06/30/2022 5:23:34 PM

Thursday, June 30, 2022 5:23:34 PM

Post# of 425931
z-

Without an IPO, Eddingpharm will have inadequate cash to pay for...

What is the basis of this? Why do you thing E- does not have = will not have enough money?

1. milestone payments

Non-sales related is less than $30M (More likely significantly less but I did not count now)

2. royalties

big smile big smile big smile Royalty is based on sold products and is not higher than 100% ... it is less. So royalty paid from the revenue

3. purchases of Vascepa shipments

We do not know the payment terms .... advance, or how many days after shipment or after the sales. It will not be a problem in any case.

Perhaps it is time for Amarin to look for another partner in China.

Because ... ?

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News